Skip to main content
Signal8

Hohneker John

SEC insider (Form 3/4/5 filer). CIK 0001695378. Director at CURIS INC (CRIS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in LEXINGTON, MA.

Companies Hohneker John has filed insider reports for

  • CURIS INC (CRIS): Director
  • ArriVent BioPharma, Inc. (AVBP): Director
Hohneker John profile photo

Hohneker John

CIK: 0001695378

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CURIS INC logo
CRIS

CURIS INC

Director
ArriVent BioPharma, Inc. logo
AVBP

ArriVent BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • CURIS INC logo
    CRIS

    CURIS INC

    Jul 7, 2026
    Award

    Non Qualified Stock Option

    Direct
    6.8K shares at avg. $5.29-
  • ArriVent BioPharma, Inc. logo
    AVBP

    ArriVent BioPharma, Inc.

    Jun 18, 2026
    Award

    Non-Qualified Stock Option (right to buy)

    Direct
    13.6K shares-
  • ArriVent BioPharma, Inc. logo
    AVBP

    ArriVent BioPharma, Inc.

    Jun 18, 2025
    Award

    Non-Qualified Stock Option (right to buy)

    Direct
    15.5K shares-
  • CURIS INC logo
    CRIS

    CURIS INC

    May 20, 2025
    Award

    Non Qualified Stock Option

    Direct
    14.4K shares at avg. $3.13-
  • CURIS INC logo
    CRIS

    CURIS INC

    Jan 28, 2025
    Award

    Non Qualified Stock Option

    Direct
    1.6K shares at avg. $3.13-

1-5 of 5